Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon® Platform 2022-07-26 11:43
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Fuzhou Rides on the Opportunity of "Digital China" to Make Its Name in the World 2022-07-25 15:21
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations 2022-07-23 00:59
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Recruitment complete for Clarity's PROPELLER prostate cancer diagnostic trial 2022-07-20 21:06
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug 2022-07-20 21:00
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML 2022-07-20 00:15
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer 2022-07-19 20:00
China Pharma Announced the Submission of a Plan of Compliance to NYSE American 2022-07-18 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics 2022-07-18 08:00
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON 2022-07-15 21:00
Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial 2022-07-15 20:30
Lunit to be Listed on KOSDAQ next week 2022-07-14 21:00
1 120 121 122 123 124 432